Revenue
No reported data
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2016
2017
2018
2019
2020
2021
2022
2023
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & development | $4.2M | $4.7M | $10.7M | $14.0M | $15.2M | $22.3M | $17.2M | $8.3M | $977,000 | $2.3M | $4.9M | $4.8M | $2.9M | $1.8M | $1.7M | $1.0M | — | — | — | — | — | — | — | — |
| Operating expenses | — | — | — | — | — | — | — | — | — | — | — | $7.4M | $5.0M | $3.5M | $3.9M | $2.6M | — | — | — | — | — | — | — | — |
| Operating income | −$10.0M | −$11.7M | −$21.4M | −$24.8M | −$24.5M | −$31.7M | −$23.0M | −$14.1M | −$5.0M | −$5.1M | −$8.5M | −$7.4M | −$4.9M | −$3.4M | −$3.9M | $2.4M | — | — | — | — | — | — | — | — |
| Net income | −$10.3M | −$11.6M | −$17.2M | −$24.3M | −$24.5M | −$31.8M | −$23.3M | −$13.9M | −$5.0M | −$5.0M | −$8.5M | −$9.2M | −$4.9M | −$3.4M | −$3.9M | −$2.4M | −$1.8M | −$3.5M | −$6.2M | −$3.3M | −$18.8M | −$73,000 | −$47,000 | −$26,000 |
| Basic EPSper diluted share | -$1.11 | -$2.31 | -$6.00 | -$0.66 | -$0.68 | -$1.07 | -$1.06 | -$0.70 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Diluted EPSper diluted share | -$1.11 | -$2.31 | -$6.00 | -$0.66 | -$0.68 | -$1.07 | -$1.06 | -$0.70 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Oct 1, 2024Form 4 | Lebovits ChaimPresident & CEO | BuyCommon Stock | 1.8K | $3.43 | $6.3K | 81.0K |
| Sep 30, 2024Form 4 | Lebovits ChaimPresident & CEO | BuyCommon Stock | 22.0K | $0.23 | $5.1K | 1.19M |
| Jul 19, 2024Form 4 | Dagher Ibrahim B.Chief Medical Officer | SellCommon Stock | 63.0K | $0.35 | $22.1K | 0 |
| May 28, 2024Form 4/A | Lebovits ChaimPresident & CEO | BuyCommon Stock | 15.0K | $0.52 | $7.8K | 1.16M |
| May 22, 2024Form 4/A | Lebovits ChaimPresident & CEO | BuyCommon Stock | 25.0K | $0.64 | $16.0K | 1.15M |